You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

Agenda

Explore the event Agenda

Filter & Search
Close
Filters
Clear
Session Type
Stream
Rooms
Day 1
Friday, 09 April 2021
Day 2
Saturday, 10 April 2021
Day 3
Sunday, 11 April 2021
10 April 2021
7:00 am
Speaker: To Be Advised
This symposium will have multiple speakers discussing the evolution of treatment targets – the psoriasis experience; translating experience in psoriasis to atopic dermatitis; and treatment targets in the Australian environment.
7:00 am
Speaker: To Be Advised
This symposium will address the underlying drivers involved in the transition from psoriasis to psoriatic arthritis, plus update you on the most recent data on the role of IL-23 in psoriatic arthritis pathogenesis and the clinical safety and efficacy demonstrated when IL-23 is inhibited from the Discover 1 and 2 Guselkumab trials.

Identification and treatment of patients with psoriasis who are at risk of psoriatic arthritis progression is an important consideration for Dermatologists. Psoriasis is a readily identifiable marker that confers risk of arthritis, the delay between onset of skin disease and the inception of joint disease may provide a therapeutic window of opportunity for altering the progression and persistence of the underlying pathophysiological mechanisms involved in the joint disease onset.
7:00 am
Speaker: To Be Advised
This symposium will provide insights from three leading dermatologists on the management of severe atopic dermatitis with Dupixent, based on case studies and panel discussion.
10 April 2021
7:59 am - 3:00 pm
Virtual Booths Open
-
A huge thank you to our Partners and Supporters for participating in the ACD ASM 2021. 

Spend some time exploring our virtual booths and see what our Partners & Supporters have to offer! 
10 April 2021
10 April 2021
9:40 am - 10:35 am
Cosmetics
Concurrent 1 - Stream 1
9:52 am
This presentation reviews the evidence for external beam laser (532nm through to 1064nm) in treating lower limb telangiectases, in the context of the author’s experience in sclerotherapy and lasers. For most patients with leg veins, sclerotherapy remains the gold standard. However, 1064nm vascular lasers can be considered for simple (non-feeder) telangiectases, telangiectatic matting and progressive essential telangiectases. 
10 April 2021
10:35 am - 10:40 am
Time for a quick stretch!
-
10 April 2021
10:40 am - 11:30 am
Genital Dermatology
Concurrent 2 - Stream 2
10:52 am
Vulval pain and Pudendal Neuralgia! You wouldn’t wish it on anyone. Whether we’re talking male cyclists coming home with their ’numb nuts’ or women with severe acute pudendal pain after childbirth, it’s far more common than usually recognised. And then there’s the chronic problem of being unable to sit, or have sex. And is it Pudendal Neuralgia or Pudendal Entrapment? We’ll discuss the lifestyle, medication, anatomical and surgical aspects. 
#Australasian College of Dermatologists Annual Scientific Meeting 2021
#Australasian College of Dermatologists Annual Scientific Meeting 2021
Home